1 Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, Ilwon-Dong, Kangnam-Gu, Seoul 135-710, Korea.
2 Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
AJR Am J Roentgenol. 2017 Oct;209(4):W202-W210. doi: 10.2214/AJR.17.17836. Epub 2017 Aug 10.
Awareness of volume doubling times (VDTs) of different thymic epithelial tumors (TETs), including low- and high-grade thymomas and thymic carcinomas, is important for their management. The purpose of this study was to evaluate the VDTs of incidentally found TETs using 3D volumetry (3D-VDT) and longest diameter (LD-VDT).
This retrospective study included 50 patients (30 men, 20 women) who had histologically proven TETs and who underwent at least two serial CT studies at greater than 2-month intervals. TETs were classified into World Health Organization subtypes and further divided into low-grade (group A [A-B1]) and high-grade (group B [B2, B3]) thymoma and thymic carcinoma (group C). Tumor volumetry was performed by either manual segmentation (3D-VDT) or longest diameter measurement (LD-VDT).
Groups A, B, and C accounted for 15, 26, and nine tumors. The median LDVDT in group A was 703.6 days (range, 286.7-1855.9 days); group B, 412.1 days (range, 130.9-716.9 days), and group C, 146.3 days (range, 68.9-448.3 days) (p < 0.01). The median 3D-VDTs were 1138.8 days (range, 350.1-3915.3 days), 711.0 days (range, 145.5-7209.5 days), and 203.1 days (range, 58.9-766.9 days) (p < 0.01). In ROC analysis, both LD-VDT (AUC, 0.873; p < 0.01; optimal cutoff value, 222.6 days; 90.2% sensitivity, 77.8% specificity) and 3DVDT (AUC, 0.859; p < 0.01; optimal cutoff value, 218.0 days; 92.7% sensitivity; 66.7% specificity) differentiated group C from groups A and B.
VDTs differ among TETs according to tumor grade. Measurement of either LD-VDT or 3D-VDT is sensitive for differentiating carcinomas from thymomas (cutoff value, ≈ 220 days).
了解不同胸腺瘤(TET)的倍增时间(VDT),包括低级别和高级别胸腺瘤和胸腺癌,对于它们的治疗非常重要。本研究旨在通过三维体积(3D-VDT)和最长直径(LD-VDT)评估偶然发现的 TET 的 VDT。
本回顾性研究纳入了 50 名经组织学证实患有 TET 且至少进行了两次 CT 检查的患者,两次检查间隔大于 2 个月。TET 分为世界卫生组织(WHO)亚型,并进一步分为低级别(A 组[A-B1])和高级别(B 组[B2,B3])胸腺瘤和胸腺癌(C 组)。通过手动分割(3D-VDT)或最长直径测量(LD-VDT)进行肿瘤体积测量。
A、B 和 C 组分别有 15、26 和 9 个肿瘤。A 组的中位 LD-VDT 为 703.6 天(范围,286.7-1855.9 天);B 组为 412.1 天(范围,130.9-716.9 天),C 组为 146.3 天(范围,68.9-448.3 天)(p<0.01)。中位 3D-VDT 分别为 1138.8 天(范围,350.1-3915.3 天)、711.0 天(范围,145.5-7209.5 天)和 203.1 天(范围,58.9-766.9 天)(p<0.01)。在 ROC 分析中,LD-VDT(AUC,0.873;p<0.01;最佳截断值,222.6 天;90.2%敏感性,77.8%特异性)和 3D-VDT(AUC,0.859;p<0.01;最佳截断值,218.0 天;92.7%敏感性;66.7%特异性)均可区分 C 组与 A 组和 B 组。
根据肿瘤分级,TET 的 VDT 不同。LD-VDT 或 3D-VDT 的测量对区分癌和胸腺瘤均具有较高的敏感性(截断值,约 220 天)。